精确瘤通过下一代测序在肝细胞癌的精确瘤
Sayali Shinde1, Carola Maria Bigogno2,3, Ana Simmons4,5
1Barts Cancer Institute, Queen Mary University of London, Cancer Research UK Barts Centre, London, UK.
Heliyon
|February 10, 2025
概括
下一代测序 (NGS) 通过识别向治疗的突变来帮助肝细胞癌 (HCC) 的精准医学. 这种方法有助于克服肝癌的耐药性,为个性化HCC治疗策略铺平了道路.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 病毒学 病毒学
背景情况:
- 肝细胞癌 (HCC) 是一种主要的肝癌,通常与乙型肝炎病毒 (HBV) 或乙型肝炎病毒 (HCV) 感染有关.
- 瘤复发和耐药性是HCC治疗的重大挑战,尽管有治疗方法.
研究的目的:
- 突出下一代测序 (NGS) 对HCC精密医学的贡献.
- 探索人工智能 (AI) 在推进HCC治疗中的潜在整合.
主要方法:
- 使用下一代测序 (NGS) 来分析HCC患者的病毒和宿主基因组.
- 识别突变和遗传异质性,以了解耐药性机制.
主要成果:
- 通过NGS,可以识别导致HCC和药物耐药性的特定突变.
- 在NGS的进步为个性化治疗策略提供了更高的准确性和吞吐量.
- 测序数据有助于开发针对耐药突变的组合疗法.
结论:
- 在肝细胞癌中,NGS是推进精准医学的关键工具.
- 将人工智能与NGS集成,有望进一步提高个性化的HCC治疗和结果.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
03:00Next-generation Sequencing
87.2K
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
87.2K